United States
Germany
Japan
United Kingdom
China
Recombinant protein of human aspartoacylase (Canavan disease) (ASPA), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Proteins
Recombinant protein of human aspartoacylase (Canavan disease) (ASPA), transcript variant 2, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human aspartoacylase (Canavan disease) (ASPA), transcript variant 2, 100 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human aspartoacylase (Canavan disease) (ASPA), transcript variant 1, 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human aspartoacylase (Canavan disease) (ASPA), transcript variant 2, 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human aspartoacylase (Canavan disease) (ASPA), transcript variant 1, 100 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
ASPA HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
ASPA HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of aspartoacylase (Canavan disease) (ASPA), transcript variant 1
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of aspartoacylase (Canavan disease) (ASPA), transcript variant 2
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression of ASPA, transcript variant 2, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of ASPA, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
